William Slikker, Jr., PhD, has been appointed Director for the National Center for Toxicological Research (NCTR, www.fda.gov/nctr).
William Slikker, Jr., PhD, has been appointed Director for the National Center for Toxicological Research (NCTR, www.fda.gov/nctr). Slikker has been serving as the Acting Director since January 4, 2006. Slikker will continue NCTR’s mission to conduct peer-reviewed research targeted at developing a scientifically sound basis for regulatory decisions and reducing risks associated with FDA-regulated products.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.